Sanofi, Regeneron lose U.S. patent challenge to Amgen cholesterol drug

By Jan Wolfe (Reuters) - Biotech company Amgen Inc said on Monday a U.S.

from Latest News World on Firstpost https://ift.tt/2Tkvrsw
via IFTTT